Research Contracts Sample Clauses

Research Contracts. (a) Employees shall not enter into contractual arrangements with parties external to the University where the contract places the Employee under an obligation to generate Intellectual Property using the Employer’s facilities or resources. With the Employee’s agreement, the Employer may enter into a contractual arrangement subject to the terms of the agreement.
AutoNDA by SimpleDocs
Research Contracts. All research contracts that the LIAFV shall execute with third party organizations, public or private, French or foreign, require signature by all Parties. In principle, they shall be negotiated by CNRS, except in exceptional circumstances and on request of the Co-principal Investigators. CNRS shall keep the other Parties informed of the results of all negotiations. The latter shall dispose of fifteen (15) days to respond, after which the negotiation is deemed approved. The research contracts are managed by the Party who negotiated them. However, the LIAFV scientific evaluation committee may request that the management of one or more contract(s) be assigned to another Party. All Parties shall be so informed. The nondisclosure clauses included in such research contracts must not preclude the concerned researchers from including their research in activity reports. The contracts shall explicitly provide provision for general expenses to be incurred by the host laboratories where the contractual activities shall be performed. The corresponding amounts, fixed jointly by the Parties, shall be allocated to the LIAFV budget. In the case of a management by CNRS, research contracts include personnel costs, and a withholding of 8% as a job loss provision contribution shall be deducted from the pre-tax amount of pay, including social and employer charges.
Research Contracts. Where Parties of the LIA enter into contracts with third party organisations for research purposes, such research contracts may be negotiated by CNRS with approval by the Steering Committee, except in exceptional circumstances and on request of the scientific coordinators. CNRS shall keep the other Parties informed of the results of all negotiations. The latter shall dispose of thirty (30) working days to respond, after which the negotiation is deemed approved. The research contracts which the Parties wish to establish, within the framework of the LIA, with public or private, French or foreign third parties organisations are signed by all the Parties. Research contracts are managed by the Party which conducted the corresponding negotiations. Nevertheless, the LIA’s Steering Committee may wish another Party to manage one or more contracts. In this case, it shall inform each Party. Non-disclosure clauses in these research contracts shall not prevent the relevant researchers from being entitled to mention their work in their activity report, which does not represent disclosure within the meaning of intellectual property legislation. The research contracts shall explicitly include provision for general expenses to be incurred by the host laboratories where the contractual activities shall be performed. The corresponding amounts, fixed jointly by the Parties, shall be reflected in the LIASFMA budget prepared by each party pursuant to Article 8. For research contracts managed by the CNRS and including non-permanent staff expenses, an 8% deduction, representing a provision for redundancy, is made on the compensation, exclusive of taxes, but including social security and employer contributions.
Research Contracts. All ISR performed under the Agreement shall be conducted in accordance with the terms of the Protocol, be consistent with applicable state and federal laws, and conform to HSC-S and LSU System and Ochsner policies and procedures. The Parties acknowledge and agree that (i) HSC-S and HSC-S Faculty must follow all HSC-S and LSU System policies and procedures to engage in any ISR and (ii) Ochsner and Ochsner Physicians must follow all Ochsner policies and procedures to engage in any ISR.
Research Contracts a. Research Agreement by and between Clintec, In Vivo, as acting agent for Clintec, and AIDS Community Research Consortium dated March 9, 1993.

Related to Research Contracts

  • Project Contracts Authority shall upon its election, succeed, without the necessity of any further action by the Concessionaire, to the interests of the Concessionaire under such of the Project Contracts as the Authority may in its discretion deem appropriate, and shall upon such election be liable to the Contractors only for compensation accruing and becoming due and payable to them under the terms of their respective Project Contracts from and after the date the Authority elects to succeed to the interests of the Concessionaire. For the avoidance of doubt, it is hereby agreed, and the Concessionaire hereby acknowledges, that all sums claimed by such Contractors as being due and owing for works and services performed or accruing on account of any act, omission or event prior to such date shall constitute debt between the Concessionaire and such Contractors, and the Authority shall not in any manner be liable for such sums. It is further agreed that in the event the Authority elects to cure any outstanding defaults under such Project Contracts, the amount expended by the Authority for this purpose shall be deducted from the Termination Payment.

  • Vendor Contracts (a) THIRD-PARTY ASO CONTRACTS.

  • Research Plans The Research Plan for the [***] Designated Target is attached as Schedule 2.2.3-1. Subsequent Research Plans agreed upon in accordance with Section 2.4.2.4 will be attached as additional sequentially numbered schedules (Schedule 2.2.3-2, Schedule 2.2.3-3, etc.).

  • Major Contracts 42 3.15 Taxes.................................................................43 3.16

  • Prior Contracts This Contract supersedes and terminates, as of the date hereof, all prior contracts between the Fund and the Custodian relating to the custody of the Fund's assets.

  • Research Licenses (a) Subject to the terms and conditions of this Agreement, each Party hereby grants to the other Party and its Affiliates, on behalf of itself and its Affiliates, a non-exclusive, royalty-free, worldwide, revocable, limited license to use, during the term of this Agreement, the Independent Technology of the owner Party, solely to permit the other Party’s (by itself and/or through its Affiliates’) performance of research and development activities in connection with the execution and implementation of any Development Program under this Agreement and/or to pursue by itself, with no third Person (not including Affiliates) involvement, independent, internal research and development initiatives outside the scope of this Agreement. In the event that a Party’s and/or its Affiliates’ (“Licensor Party”) Independent Technology is used under the license granted in this Section 7.3 (a) by the other Party and/or its Affiliates (“Licensee Party”) to pursue independent research and development initiatives outside the scope of this Agreement and such initiatives result in the creation or development of any Invention and/or Technology, the Licensee Party hereby grants and agrees to grant to the Licensor Party, a non-exclusive, royalty-free, worldwide license under such Invention and/or Technology, as well as any Intellectual Property Rights derived from such Invention and/or Technology.

  • Research Program 2.1 University will use reasonable efforts to conduct the Research Program described in Attachment A which is hereby incorporated in full by reference (“Research Program”), and will furnish the facilities necessary to carry out said Research Program. The Research Program will be under the direction of _____________________ (“Principal Investigator”), or his or her successor as mutually agreed to by the Parties and will be con­ducted by the Principal Investigator at the University.

  • Research Records Each Party shall maintain records of each Research Program (or cause such records to be maintained) in sufficient detail and in good scientific manner as will properly reflect all work done and results achieved by or on behalf of such Party in the performance of such Research Program. All laboratory notebooks shall be maintained for no less than the term of any Patent issuing therefrom. All other records shall be maintained by each Party during the relevant Research Term and for [**] thereafter. All such records of a Party shall be considered such Party’s Confidential Information.

  • Research Matters By entering into this Agreement, the Placement Agent does not provide any promise, either explicitly or implicitly, of favorable or continued research coverage of the Company and the Company hereby acknowledges and agrees that the Placement Agent’s selection as a placement agent for the Offering was in no way conditioned, explicitly or implicitly, on the Placement Agent providing favorable or any research coverage of the Company. In accordance with FINRA Rule 2711(e), the parties acknowledge and agree that the Placement Agent has not directly or indirectly offered favorable research, a specific rating or a specific price target, or threatened to change research, a rating or a price target, to the Company or inducement for the receipt of business or compensation.

  • Research Collaboration Upon FibroGen’s request, the Parties will discuss conducting a research program funded by AstraZeneca and directed toward franchise enhancement and lifecycle management for HIF Compounds or other topics that the Parties determine relevant to the Products and the Field. Upon agreement on the terms of such research program, the Parties will enter into a separate agreement or amend this Agreement accordingly.

Draft better contracts in just 5 minutes Get the weekly Law Insider newsletter packed with expert videos, webinars, ebooks, and more!